Using the Acrysof® ReSTOR® Intraocular Lens in Cataract Surgery for Presbyopia
Prepared for the web by Andrew Doan, MD, PhD
Photos and diagrams were provided by Alcon and Stephen Lane, MD (University of Minnesota).
**Dr. Johnson has no financial interests in the products discussed below**
The latest addition into the market of presbyopia-correcting intraocular lenses (IOLs) is the Acrysof ® ReSTOR ®. This lens received approval by the FDA on March 21, 2005. The proposed benefit of these lenses is to provide excellent vision at distance and near, with independence from spectacle use.
In the United States, there are currently three options to choose from when considering a lens to correct presbyopia:
- Array lens from Advanced Medical Optics
- Crystalens ® from Eyeonics
- ReSTOR ® lens from Alcon (Fig. 1)
Until recently, this new technology was not available to all patients, specifically patients insured by Medicare. On May 22, 2005 the director of the Center for Medicare and Medicaid Services announced that patients covered by Medicare could choose presbyopia-correcting intraocular lenses at the time of cataract surgery. This opened the door to the new technology previously unavailable to millions of patients contemplating cataract removal.
Mechanism of ReSTOR ® Lens
The unique feature of the ReSTOR ® lens is the apodized diffractive optics (Figure 2). The concept of apodization means a gradual transition of optical properties from the center of a lens to the edge. In this case there are a series of twelve diffractive rings over the central 3.6 millimeters of the lens optic. The inner most ring has a step height of 1.3 microns with subsequent rings gradually decreasing in height until the outer ring with a height of 0.2 microns. The inner rings are further apart and the distance between rings gradually decreases toward the periphery (Figure 3). The add power is 4.0 D at the IOL plane and 3.2 D at the spectacle plane.
|Figure 2: Apodized diffractive optics.||Figure 3: Diffractive rings.|
FDA Data on Safety and Effectiveness
The FDA data on safety and effectiveness can be found at: http://www.fda.gov/cdrh/pdf4/p040020.html. This study enrolled 820 patients, 760 of whom were evaluated at one year of follow-up. Five hundred sixty six patients were implanted with the ReSTOR ®, while 194 patients received an AcrySof ® monofocal lens. Five hundred forty nine of the ReSTOR ® patients had the fellow eye implanted with the multifocal lens and 181 of the monofocal controls were implanted in the fellow eye.
The study results for binocular uncorrected distance and near visual acuities with the ReSTOR ® lens are shown in Figures 4 and 5.
|Figure 4: Distance visual acuities were equivalent for the two groups, exceeding the FDA grid for best corrected distance visual acuity.||Figure 5: Uncorrected near visual acuity was markedly better in the patients receiving the multifocal lens, with nearly 90% achieving vision of J2 or better versus only 24% of patients receiving the monofocal control.|
When combining distance and near visual acuity, 84% of patients receiving the ReSTOR ® lens achieved a level of 20/25 and J2 or better without spectacles, and 97% achieved 20/40 or better and distance and near. Monofocal patients achieved 20/25 and J2 without correction in 23% and 20/40 or better in 41% (Figure 6).
The ReSTOR ® lens provides adequate mid-range vision, and thus a visual acuity of 20/40 or better is possible throughout the range from infinity to 22 cm. When stratified by pupil size, the curves are within one line among the groups less than 2.5 mm, 2.5-4 mm and greater than 4 mm (Figure 7).
|Figure 6: Combined Binocular Distance and Near VA||Figure 7: Range of Vision|
|Visual disturbances, particularly in nighttime driving conditions, have been the biggest challenge of multifocal lenses. Approximately 25% of patients experience some degree of glare and halos. This compares to 3 to 9% of patients with the monofocal lens (Figure 8).|
The ReSTOR compares favorably with the Array and the Crystalens in visual disturbances (Figures 9 and 10).
The ability to detect road signs or hazards is reduced in patients implanted with the ReSTOR lens compared to monofocal controls. Under most conditions, the mean differences were less than 15%. However, under glare conditions, the ability of patients with the ReSTOR lens to identify text in signs was reduced by 28%.
|Figure 9: Visual Disturbances||Figure 10: Visual Disturbances|
The apodized diffractive optics was designed to reduce visual disturbances compared to previous designs. In low light conditions where the pupil size is larger, the proportion of energy dedicated to the near image is less than 10%. This compares with approximately 50% for the Array lens (Figures 11 and 12).
|Figure 11: Apodized Diffractive Optics||Figure 12: Zonal Refractive Optics|
The promise of spectacle independence is what patients will be expecting when choosing a multifocal lens. Patients implanted with the ReSTOR lens reported the highest degree of spectacle independence among all presbyopia-correcting lenses (Figure 13).
Patient selection is important, as is careful discussion of the benefits and limitations of this lens.
Good patient characteristics include:
- patients motivated to be free of spectacles for near and distance
- patients with cataracts with or without presbyopia
- patients needing bilateral lens implantation
Poor patient characteristics include:
- patients with unrealistic expectations for visual improvement
- patients with excessive complaints about spectacles or contact lenses
- patients not tolerant of monovision
- patients whose occupation requires night driving
- patients happy wearing glasses
- patients with complaints about night time glare
Accurate biometry and control of astigmatism are essential to deliver on the promise of spectacle independence. The lens constant must be carefully personalized to the individual surgeon. Post-operative astigmatism needs to be reduced to one diopter or less. For patients with astigmatism greater than this, limbal relaxing incisions, LASIK, or other corneal refractive procedures may be needed.
If you need more information or would like to schedule an appointment to see Dr. Johnson, then you may email him or contact the scheduling office at the University of Iowa Dept. of Ophthalmology and Visual Sciences.